(617) 726 – 5050
MGHonconephrology@mgh.harvard.edu
Give Today

MYTHIC Trial

By |2022-02-14T08:43:04-05:00June 30th, 2017|

MYTHIC Trial Significance Statement Single-center trials and retrospective case series have reported promising outcomes transplanting kidneys from donors with hepatitis C virus (HCV) infection into HCV-negative recipients, although concerns remain about immunologic complications. In this first multicenter trial, 30 HCV-uninfected adults received a kidney from an HCV-viremic deceased donor and [...]

COVID-19 & CKD

By |2022-02-14T07:40:58-05:00June 30th, 2017|

COVID-19 Survival and its impact on chronic kidney disease Abstract Up to 87% of patients hospitalized with coronavirus disease 2019 (COVID-19) experience chronic sequelae following infection. The long-term impact of COVID-19 infection on kidney function is largely unknown at this point in the COVID-19 pandemic. In this review, we highlight [...]

Renal Toxicities with Immune Checkpoint Inhibitors

By |2022-02-14T07:52:43-05:00June 30th, 2017|

Renal Toxicities with Immune Checkpoint Inhibitors Abstract Immune checkpoint inhibitors are now approved for more than 50 indications, and increasing numbers of patients with advanced cancer are receiving immunotherapy. Immune-related adverse events that result from checkpoint inhibitors can affect any organ system. The most common kidney side effect is acute [...]

Go to Top